Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Roblox Is What Retail Investors Wish GameStop Could Be

The Roblox business model showcases the future of gaming. Speculative investors may find RBLX stock to be what they imagined GameStop was.

Star Peak Energy and Stem Will Not Be a Secret For Much Longer

Although not a household name, STPK stock is likely to climb as energy storage becomes a priority for green energy companies.

UWM Holding May Win a Broker Battle With Rocket That’s Not Worth Fighting

UWM declared victory after it effectively extracted a loyalty pledge from mortgage brokers. However, the victory shouldn't be your reason to buy UWMC stock.

Castor Maritime Isn’t Just a Meme Play, but It’s Still a High-Risk Proposition

After two years in which Castor Maritime and other shippers have faced significant headwinds, is CTRM stock a buy with an expected shipping boom?

7 Vital Cybersecurity Stocks for the Work-From-Home World

Remote work in some form is here to stay. Here are seven cybersecurity stocks that will continue to offer growth for investors.

Will This Really Be the Golden Age of Ripple?

Ripple remains an intriguing cryptocurrency. It may take a while for XRP to surpass its all-time high, but the odds it can may have gotten a lot better.

Investing in Asensus Surgical Requires the Patience of a Surgeon

ASXC stock is extremely overvalued. And that means that investors may be waiting a long time for the stock to meet its lofty expectations.

7 Stocks That You Should Leave Out of Your Retirement Portfolio

When it comes to your retirement, these stocks have some qualities that investors should typically look for, but they have some less attractive qualities as well.

Avoid SOLO Stock as Its Story Looks Less and Less Compelling

ElectraMeccanica Vehicles still faces hurdles for long-term adoption of its Solo autocycle. Until those are answered, I'm not sure there are enough reasons beyond price to buy SOLO stock.

Look Beyond The Headlines Before Deciding on Palantir Stock

The analyst community is sour on PLTR stock and institutional investors have tepid interest. But that's just the way Palantir likes it.